Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NAC for Amputation Stump Healing in Diabetes
NCT03253328Phase 1Completed
- Sponsor
- Washington University School of Medicine
- Start
- Mar 2017
- Primary completion
- Aug 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in critical limb ischemia (CLI) comparing Active Arm N-acetyl cysteine (NAC) with Placebo Arm (2 arms). Primary endpoints: Change in Postoperative Laser-Assisted Fluorescent Angiography (LAFA) Perfusion at Day 5 and Stump Healing Assessment at Postoperative Day (POD) 30 at 30 days. Started Mar 2017; status: completed.
02
Drugs
acetylcysteine
03
Conditions
critical limb ischemia (CLI)
Beyond the preview
Go deeper on NCT03253328.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03253328.